Skip to content

MiMedx Group MDXG Operating Cash Flow

Operating Cash Flow at other companies

IAR
Integra LifeSciencesIART
$9.8M+187%
Artivion logo
ArtivionAORT
$1.15M+107%
Solventum logo
SolventumSOLV
-$189M-752%
Vericel logo
VericelVCEL
$16.38M+148%
Enovis logo
EnovisENOV
$23.95M+1,601%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
-$339K-181%

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's operating cash flow?
MiMedx Group (MDXG) reported operating cash flow of $1.88M in Q1 2026.
How has MiMedx Group's operating cash flow changed year-over-year?
MiMedx Group's operating cash flow decreased by 64.5% year-over-year, from $5.3M to $1.88M.
What is the long-term trend for MiMedx Group's operating cash flow?
Over 3 years (2022 to 2025), MiMedx Group's operating cash flow has grown at a 57.7% compound annual growth rate (CAGR), from -$18.85M to $74M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.